RecruitingNCT05570110
Official study titleDouble-blind Randomized Placebo Controlled Study on the Effect of Enoxolone ( 11-beta Hydroxysteroid-dehydrogenase Type 2 Inhibitor) on the RAAS, Autonomic and Imaging Biomarkers and the Outcome of Depression
In MarburgDepressionMedication studyAges 18+
- Countries
- Germany
- Sponsor
- Philipps University Marburg
RecruitingNCT05892744
Official study titleEstablishing Multimodal Brain Biomarkers Using Data-driven Analytics for Treatment Selection in Depression
In AustinDepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- University of Texas at Austin
RecruitingNCT07105397
In FairfaxDepressionInterventional studyAges 18–85
- Countries
- United States
- Sponsor
- George Mason University
RecruitingNCT06830044
What is this study about?This study evaluates the safety and effectiveness of Milsaperidone for people with depression.
Multiple locations, including PhoenixDepressionMedication studyAges 18–65
- Countries
- United States, Bulgaria, Czechia, + 1 other
- Sponsor
- Vanda Pharmaceuticals
RecruitingNCT07228468
What is this study about?Researchers are comparing electrical stimulation of the brain using tDCS and usual care to find out how the approaches affect depression symptoms in people with depression.
In LondonDepressionDevice studyAges 18+
- Countries
- United Kingdom
- Sponsor
- King's College London (University)
RecruitingNCT06805851
Official study titleThermoregulatory Responses to Heat Stress in Adults With Major Depressive Disorder With and Without Antidepressant Treatment
In University ParkDepressionObservational studyAges 18–40
- Countries
- United States
- Sponsor
- Penn State University
RecruitingNCT06990035
Official study titleImplementazione di un Intervento Multiplo Per Promuovere Stili di Vita Sani in Pazienti Con Depressione: Uno Studio Clinico Controllato e Randomizzato
Multiple locations, including BresciaDepressionBehavioural studyAges 55–80
- Countries
- Italy
- Sponsor
- IRCCS Centro San Giovanni di Dio Fatebenefratelli
RecruitingNCT07217444
In CincinnatiDepression, SuicidalityDevice studyAges 14–18
- Countries
- United States
- Sponsor
- Children's Hospital Medical Center, Cincinnati
RecruitingNCT07263321
Official study titleOptimising Treatment for Patients With Depressive Episodes in General Practice Through Algorithm-Based Treatment: A Randomised, Open-label Controlled Trial.
In AalborgDepressionInterventional studyAges 18–65
- Countries
- Denmark
- Sponsor
- Aalborg University Hospital
RecruitingNCT06392867
In Hong KongDepressionDevice studyAges 18–70
- Countries
- China
- Sponsor
- The Hong Kong Polytechnic University
RecruitingNCT07230990
Official study titleMechanisms Of Orbitofrontal Stimulation in Depression (MOOD)
In BostonDepressionDevice studyAges 18–65
- Countries
- United States
- Sponsor
- Subha Subramanian
RecruitingNCT07015944
Official study titleClinical and Cost-effectiveness of an Integrated Psychosocial Care Plan for Comorbid Depression in Breast Cancer Survivors In Pakistan: A Sequential Multiple Assignment Randomised Trial
In KarachiDepressionMedication studyAges 18+
- Countries
- Pakistan
- Sponsor
- Pakistan Institute of Living and Learning
Data coveragePublic registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.